Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Texas Health Presbyterian Hospital Dallas located at 8200 Walnut Hill Lane, Dallas, TX, 75231 & includes data from NPIs 1255412789, 1245311695, 1396779948
Dexur analyzed Q3 2017 (July to September 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Texas Health Presbyterian Hospital Dallas compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,124 | 2,060 | ||||||||||
| Surgical | 775 | 765 | ||||||||||
| Non Surgical | 1,349 | 1,295 | ||||||||||
| Orthopedics | 415 | 406 | ||||||||||
| Cardiovascular | 411 | 400 | ||||||||||
| General Medicine | 220 | 207 | ||||||||||
| Neurology | 216 | 207 | ||||||||||
| General Surgery | 185 | 181 | ||||||||||
| Gastroenterology & Endocrinology | 159 | 152 | ||||||||||
| Urology | 159 | 158 | ||||||||||
| Pulmonology | 109 | 106 | ||||||||||
| Psychiatry & Mental Disorders | 86 | 83 | ||||||||||
| Oncology & Hematology | 54 | 52 | ||||||||||
| Colorectal | 32 | 30 | ||||||||||
| Spine | 27 | 27 | ||||||||||
| Dermatology | 22 | 22 | ||||||||||
| Obstetrics & Gynecology | 18 | 18 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 11 | 11 |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 561: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| Amputation For Circulatory System Disorders Except Upper Limb And Toe |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| Coronary Bypass | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||
| Hypertension | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare | ||||||||||||
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Complications Of Treatment | ||||||||||||
| Poisoning And Toxic Effects Of Drugs |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
| Seizures |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extracranial Procedures | ||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||
| Hernia Procedures |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Diabetes | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| Cholecystectomy |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||
| Alcohol/Drug Abuse Or Dependence | ||||||||||||
| DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2017 to Sep 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trauma To The Skin, Subcutaneous Tissue And Breast |